For the quarter ending 2026-03-31, NXL had $553,112 increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Non-cash lease expense | - | - | - | 0 |
| Net loss | -2,096,837 | -2,376,546 | -2,276,311 | -3,569,324 |
| Stock compensation | 478,611 | 831,529 | 1,082,790 | 1,208,944 |
| Depreciation | 4,107 | - | - | - |
| Amortization | 6,736 | 6,152 | 5,473 | 9,912 |
| Write off of inventory | - | 16,380 | - | - |
| Gain on sale of short-term investments | 21,025 | 27,609 | 46,774 | 52,557 |
| Return on investment in joint venture | - | 0 | 0 | 864 |
| Accounts receivable | -755 | 35,833 | -51,916 | 49,805 |
| Accounts receivable- related party | -37,812 | 37,812 | 0 | -3,007 |
| Prepaid assets | -3,838 | 119,503 | - | -50,086 |
| Lease liability | - | - | - | 0 |
| Prepaid expenses and other current assets | - | - | 2,954 | - |
| Accrued expenses - related party | - | - | -22,000 | -12,000 |
| Inventory | 48,016 | -12,372 | -12,749 | -1,604 |
| Accounts payable - related party | - | - | -4,859 | 7,770 |
| Other assets | - | - | - | 0 |
| Accounts payable | -76,480 | 179,996 | -168,228 | 76,861 |
| Accrued expenses | -2,489 | 318,723 | -47,973 | -18,741 |
| Net cash used in operating activities | -1,712,988 | -1,148,022 | -1,466,257 | -2,343,379 |
| Sale of short-term investments | 5,589,606 | 9,478,000 | 13,546,000 | 17,701,000 |
| Purchase of short-term investments | 4,000,654 | 8,755,181 | 11,901,824 | 20,103,127 |
| Purchase of equipment | 49,276 | - | - | - |
| Purchase of patents | 14,065 | 13,609 | 11,118 | 35,215 |
| Purchase of trademarks | 15,932 | 20,030 | 8,046 | 8,841 |
| Net cash provided by investing activities | 1,509,679 | 689,180 | 1,625,012 | -2,446,183 |
| Sale of common stock for cash, net of financing fees | - | 0 | 0 | 4,646,397 |
| Proceeds from atm, net of fees | 756,421 | 523,550 | - | - |
| Net cash provided by financing activities | 756,421 | 523,550 | 0 | 4,646,397 |
| Net increase in cash and cash equivalents | 553,112 | 64,708 | 158,755 | -143,165 |
| Cash and cash equivalents - beginning of period | 654,783 | 590,075 | 574,485 | - |
| Cash and cash equivalents - end of period | 1,207,895 | 654,783 | 590,075 | - |
Nexalin Technology, Inc. (NXL)
Nexalin Technology, Inc. (NXL)